Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman
J
J
Department of Psychiatry, Mount Sinai Medical Center, New York, New York 10029, USA.
Ault
K
K
Powchik
P
P
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010868:Pimozide / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D010868:Pimozide; D003024:Clozapine